Warning: The NCBI web site requires JavaScript to function. more...
Retinoid X receptor and peroxisome proliferator-activated receptor-gamma agonists cooperate to inhibit matrix metalloproteinase gene expression.
Burrage PS, Schmucker AC, Ren Y, Sporn MB, Brinckerhoff CE.
Arthritis Res Ther. 2008;10(6):R139. Epub 2008 Dec 1.
Related citations
Regulation of matrix metalloproteinase gene expression by a retinoid X receptor-specific ligand.
Burrage PS, Huntington JT, Sporn MB, Brinckerhoff CE.
Arthritis Rheum. 2007 Mar;56(3):892-904.
Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer.
Park EY, Cho IJ, Kim SG.
Cancer Res. 2004 May 15;64(10):3701-13.
A peroxisome proliferator-activated receptor gamma-retinoid X receptor heterodimer physically interacts with the transcriptional activator PAX6 to inhibit glucagon gene transcription.
Krätzner R, Fröhlich F, Lepler K, Schröder M, Röher K, Dickel C, Tzvetkov MV, Quentin T, Oetjen E, Knepel W.
Mol Pharmacol. 2008 Feb;73(2):509-17. Epub 2007 Oct 25.
Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
Moulin D, Bianchi A, Boyault S, Sebillaud S, Koufany M, Francois M, Netter P, Jouzeau JY, Terlain B.
Arthritis Rheum. 2005 Mar;52(3):759-69.
Interleukin-4 inhibition of interleukin-1-induced expression of matrix metalloproteinase-3 (MMP-3) is independent of lipoxygenase and PPARgamma activation in human gingival fibroblasts.
Stewart D, Javadi M, Chambers M, Gunsolly C, Gorski G, Borghaei RC.
BMC Mol Biol. 2007 Feb 23;8:12.
Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells.
Han S, Sidell N, Fisher PB, Roman J.
Clin Cancer Res. 2004 Mar 15;10(6):1911-9.
Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor gamma involves angiogenesis inhibition.
Dong YW, Wang XP, Wu K.
World J Gastroenterol. 2009 Jan 28;15(4):441-8.
Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
Magenta G, Borenstein X, Rolando R, Jasnis MA.
BMC Cancer. 2008 Feb 8;8:47.
Distinct mechanisms of glucose lowering by specific agonists for peroxisomal proliferator activated receptor gamma and retinoic acid X receptors.
Li X, Hansen PA, Xi L, Chandraratna RA, Burant CF.
J Biol Chem. 2005 Nov 18;280(46):38317-27. Epub 2005 Sep 22.
Enhanced effects of PPARgamma ligands and RXR selective retinoids in combination to inhibit migration and invasiveness in cancer cells.
Papi A, Rocchi P, Ferreri AM, Guerra F, Orlandi M.
Oncol Rep. 2009 Apr;21(4):1083-9.
Regulation of aromatase by nuclear receptors.
Yanase T, Mu YM, Nishi Y, Goto K, Nomura M, Okabe T, Takayanagi R, Nawata H.
J Steroid Biochem Mol Biol. 2001 Dec;79(1-5):187-92.
Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
Lin MS, Chen WC, Bai X, Wang YD.
J Dig Dis. 2007 May;8(2):82-8.
Peroxisome proliferator-activated receptor-gamma down-regulates chondrocyte matrix metalloproteinase-1 via a novel composite element.
François M, Richette P, Tsagris L, Raymondjean M, Fulchignoni-Lataud MC, Forest C, Savouret JF, Corvol MT.
J Biol Chem. 2004 Jul 2;279(27):28411-8. Epub 2004 Apr 16.
Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists.
Nie M, Corbett L, Knox AJ, Pang L.
J Biol Chem. 2005 Jan 28;280(4):2550-61. Epub 2004 Nov 5.
Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells.
Galli A, Crabb D, Price D, Ceni E, Salzano R, Surrenti C, Casini A.
Hepatology. 2000 Jan;31(1):101-8.
Peroxisome proliferator-activated receptor gamma activators inhibit MMP-1 production in human synovial fibroblasts likely by reducing the binding of the activator protein 1.
Fahmi H, Pelletier JP, Di Battista JA, Cheung HS, Fernandes JC, Martel-Pelletier J.
Osteoarthritis Cartilage. 2002 Feb;10(2):100-8.
Activation of the peroxisome proliferator-activated receptor alpha pathway potentiates interleukin-1 receptor antagonist production in cytokine-treated chondrocytes.
François M, Richette P, Tsagris L, Fitting C, Lemay C, Benallaoua M, Tahiri K, Corvol MT.
Arthritis Rheum. 2006 Apr;54(4):1233-45.
9-cis-Retinoic acid (9cRA), a retinoid X receptor (RXR) ligand, exerts immunosuppressive effects on dendritic cells by RXR-dependent activation: inhibition of peroxisome proliferator-activated receptor gamma blocks some of the 9cRA activities, and precludes them to mature phenotype development.
Zapata-Gonzalez F, Rueda F, Petriz J, Domingo P, Villarroya F, de Madariaga A, Domingo JC.
J Immunol. 2007 May 15;178(10):6130-9.
Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
Bianchi A, Moulin D, Sebillaud S, Koufany M, Galteau MM, Netter P, Terlain B, Jouzeau JY.
Arthritis Res Ther. 2005;7(6):R1325-37. Epub 2005 Sep 22.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on